Sarcopenia in copd: Prevalence, clinical correlates and response to pulmonary rehabilitation

Thorax

Volumn 70, Issue 3, 2015, Pages 213-218

  Jones, Sarah E ^a   Maddocks, Matthew ^b   Kon, Samantha S C ^a   Canavan, Jane L ^a   Nolan, Claire M ^a   Clark, Amy L ^a   Polkey, Michael I ^a   Man, William D C ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; EXERCISE; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HEALTH STATUS; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; OUTPATIENT; PATIENT CODING; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRACTICE GUIDELINE; PREVALENCE; PROPENSITY SCORE; PULMONARY REHABILITATION; QUADRICEPS FEMORIS MUSCLE; RISK ASSESSMENT; RISK FACTOR; SARCOPENIA; SEX DIFFERENCE; TREATMENT RESPONSE; AGE; CASE CONTROL STUDY; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; WALKING;

AGE FACTORS; AGED; AGED, 80 AND OVER; BODY COMPOSITION; CASE-CONTROL STUDIES; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; PREVALENCE; PROPENSITY SCORE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; SARCOPENIA; SEVERITY OF ILLNESS INDEX; WALKING;

EID: 84923170901     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206440     Document Type: Article

References (35)

1. Maltais F, Decramer M, Casaburi R, et al. An of ficial American Thoracic Society/ European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;189:e15-62.
2. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36:81-8.
3. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012;40:1115-22.
4. Natanek SA, Gosker HR, Slot IG, et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratifi ed medicine? Muscle Nerve 2013;48:488-97.
5. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62:115-20.
6. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-13.
7. Patel MS, Natanek SA, Stratakos G, et al. Vastus lateralis fiber shift is an independent predictor of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;190:350-2.
8. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on defi nition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-23.
9. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014;2:819-29.
10. Donaldson AV, Maddocks M, Martolini D, et al. Muscle function in COPD: a complex interplay. Int J Chron Obstruct Pulmon Dis 2012;7:523-35.
11. Spruit MA, Watkins ML, Edwards LD, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 2010;104:849-57.
12. Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2014;69:438-46.
13. Gariballa S, Alessa A. Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clinical Nutrition 2013;32:772-6.
14. Vetrano DL, Landi F, Volpato S, et al. Association of Sarcopenia With Short- and Long-term Mortality in Older Adults Admitted to Acute Care Wards: Results From the CRIME Study. J Gerontol A Biol Sci Med Sci 2014;69:1154-61.
15. Steiner MC. Sarcopaenia in chronic obstructive pulmonary disease. Thorax 2007;62:101-3.
16. Schols AM, Ferreira IM, Franssen FM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014;44:1504-20. pii: erj00709-2014.
17. Steiner MC, Roubenoff R, Tal-Singer R, et al. Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review. Thorax 2012;67:1102-9.
18. Kon SS, Patel MS, Canavan JL, et al. Reliability and validity of 4-metre gait speed in COPD. Eur Respir J 2013;42:333-40.
19. Kon SS, Canavan JL, Nolan CN, et al. The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference. Eur Respir J 2014;43:1298-305.
20. Janssen I, Baumgartner RN, Ross R, et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21.
21. Lauretani F, Russo CR, Bandinelli S, et al . Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985) 2003;95:1851-60.
22. Garfield BE, Canavan JL, Smith CJ, et al. Stanford Seven-Day Physical Activity Recall questionnaire in COPD. Eur Respir J 2012;40:356-62.
23. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
24. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011;12:403-9.
25. Steiner MC, Barton RL, Singh SJ, et al. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002;19:626-31.
26. Patel HP, Syddall HE, Jameson K, et al. Prevalence of sarcopenia in communitydwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 2013;42:378-84.
27. Legrand D, Vaes B, Mathei C, et al. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing 2013;42:727-34.
28. Smoliner C, Sieber CC, Wirth R. Prevalence of sarcopenia in geriatric hospitalized patients. J Am Med Dir Assoc 2014;15:267-72.
29. Rossi AP, Fantin F, Micciolo R, et al. Identifying sarcopenia in acute care setting patients. J Am Med Dir Assoc 2014;15:303 e7-12.
30. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
31. Liu CK, Leng X, Hsu FC, et al. The impact of sarcopenia on a physical activity intervention: the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P). J Nutr Health Aging 2014;18:59-64.
32. Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respiratory Medicine 2014;2:195-203.
33. Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1447-78. pii: erj01504-2014.
34. Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 2013;42:203-9.
35. Polkey MI, Spruit MA, Edwards LD, et al. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013;187:382-6.